泪道设备市场规模、份额和成长分析（按产品、应用、最终用途和地区）- 产业预测 2025-2032

2023 年泪道设备市场规模价值为 1.6519 亿美元，预计将从 2024 年的 1.7147 亿美元增长到 2032 年的 2.3108 亿美元，预计在预测期内（2025-2032 年）的复合年增长率为 3.8%。

随着各个年龄层的人对眼部疾病的认识和诊断不断提高，泪道设备市场正在经历强劲增长。随着眼部疾病的增多，对穿刺塞、泪点支架、灌溉系统等先进设备的需求也日益增加。技术进步和手术技术的改进正在改善患者的治疗效果，进一步推动市场的扩张。人口老化，加上与老龄化相关的眼科疾病的快速增加，推动了这一增长轨迹。製造商和医疗保健提供者註重护理品质和舒适度，正在创新解决方案以满足泪液疾病患者的需求。监管因素和报销政策也对市场动态重大影响。总体而言，市场为专注于以患者为中心的解决方案和改善治疗结果的眼科设备製造商提供了有利可图的机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

泪道设备市场规模（依产品及复合年增长率） (2025-2032)

• 市场概况
• 插管套件
• 支架和管
• 套管和刮刀
• 扩充器

泪道设备市场规模（依应用划分）及复合年增长率（2025-2032）

• 市场概况
• 青光眼
• 眼睛干涩
• 泪腺发炎
• 溢泪
• 其他的

泪道设备市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 诊断中心
• 门诊护理中心 (ACC)

泪道设备市场规模（依地区划分）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• FCI Ophthalmics（France）
• Kaneka Corporation（Japan）
• Cook Group（USA）
• BVI（UK）
• Rumex International（USA）
• Bess Medical Technology GmbH（Germany）
• Bausch and Lomb Incorporated（USA）
• Braun Melsungen AG（Germany）
• OASIS Medical, Inc.（USA）
• Beaver-Visitec International（USA）
• FC Optics Ltd.（Israel）
• OptiMedica Corporation（USA）
• Diamatrix Ltd.（UK）
• FCI SAS（France）
• Novartis AG（Switzerland）
• Eye Kon Medical, Inc.（USA）

结论和建议

Lacrimal Devices Market size was valued at USD 165.19 million in 2023 and is poised to grow from USD 171.47 million in 2024 to USD 231.08 million by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032).

The lacrimal devices market is experiencing robust growth driven by heightened awareness and diagnosis of ophthalmic conditions across all age demographics. With a rise in eye-related disorders, there's an increased demand for advanced devices like punctal plugs, lacrimal stents, and irrigation systems. Technological advancements and improved surgical techniques have enhanced patient outcomes, propelling market expansion further. The aging population, coupled with a surge in age-related ocular issues, sustains this growth trajectory. Manufacturers and healthcare providers are innovating solutions tailored to address the needs of patients with lacrimal disorders, emphasizing quality of care and comfort. Regulatory factors and reimbursement policies also significantly impact market dynamics. Overall, this market presents lucrative opportunities for ophthalmic device companies focused on patient-centric solutions and enhanced treatment results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Lacrimal Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Lacrimal Devices Market Segments Analysis

Global Lacrimal Devices Market is segmented by Product, Application, End-use and region. Based on Product, the market is segmented into Intubation Sets, Stents and Tubes, Cannula and Spatula and Dilators. Based on Application, the market is segmented into Glaucoma, Dry Eye, Lacrimal Gland Inflammation, Epiphora and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Care Centers (ACC). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Lacrimal Devices Market

The lacrimal devices market is primarily driven by the rising prevalence of eye disorders worldwide. Contributing factors include an aging population, evolving lifestyles, and increased screen time, all of which have led to a surge in conditions such as dry eye syndrome and other disorders affecting the lacrimal system. As a result, there is a heightened demand for lacrimal devices designed to facilitate the diagnosis and treatment of these issues, significantly stimulating market expansion. Furthermore, greater awareness and advances in technology are likely to enhance the adoption of these devices, further fueling growth in the lacrimal devices sector.

Restraints in the Lacrimal Devices Market

A significant constraint in the lacrimal devices market is the tough regulatory environment, along with the potential for delays in securing approvals for new products or modifications. In regions like North America and Europe, regulatory agencies impose rigorous standards for medical devices, which can extend the time required for market entry. These challenges not only hinder the pace of innovation but also affect market expansion, presenting difficulties for both established companies and new market entrants. Consequently, navigating this complicated approval process can stunt overall growth within the lacrimal devices sector, limiting opportunities for advancement and development.

Market Trends of the Lacrimal Devices Market

The lacrimal devices market is witnessing a pronounced shift towards minimally invasive procedures, reflecting a broader trend in healthcare that prioritizes patient comfort and quicker recovery. Both patients and healthcare professionals are increasingly favoring techniques that minimize surgical intervention for lacrimal system disorders, resulting in fewer postoperative complications. This growing demand for less invasive solutions has spurred innovation in the development of advanced lacrimal devices, including microendoscopes, specialized catheters, and other state-of-the-art tools. As these technologies evolve, they are set to enhance treatment efficacy and redefine patient care standards, positioning minimally invasive options as the preferred choice in the lacrimal devices market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Lacrimal Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Intubation Sets
• Stents and Tubes
• Cannula and Spatula
• Dilators

Global Lacrimal Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Glaucoma
• Dry Eye
• Lacrimal Gland Inflammation
• Epiphora
• Others

Global Lacrimal Devices Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Ambulatory Care Centers (ACC)

Global Lacrimal Devices Market Size & CAGR (2025-2032)

• North America (Product, Application, End-use)
  • US
  • Canada
• Europe (Product, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• FCI Ophthalmics (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BVI (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rumex International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bess Medical Technology GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch and Lomb Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OASIS Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beaver-Visitec International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FC Optics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMedica Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diamatrix Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FCI S.A.S. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Kon Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations